MedTrace Logo

Prevalence of Trismus in Patients With Maxillary Cancer With and Without Radiation Therapy in the Egyptian Population.

NCT05091814 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 360

Last updated 2021-10-25

No results posted yet for this study

Summary

This study aims at evaluating the prevalence of trismus among maxillary cancer patients in the Egyptian population and the effect of radiotherapy on the occurrence of trismus.

Conditions

  • Maxillary Neoplasms

Interventions

RADIATION

radiotherapy

patients who recieved radiotherapy after surgical removal of the tumor

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Cairo University

    lead OTHER

Principal Investigators

  • Gamal Ashour · National Cancer Institute (NCI)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-31
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05091814 on ClinicalTrials.gov